Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197


Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.

Kang W, Seol HJ, Seong DH, Kim J, Kim Y, Kim SU, Nam DH, Joo KM.

Oncol Rep. 2013 Sep;30(3):1101-6. doi: 10.3892/or.2013.2584. Epub 2013 Jul 3.


Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.

Yi BR, Kim SU, Kim YB, Lee HJ, Cho MH, Choi KC.

Oncol Rep. 2012 Jun;27(6):1823-8. doi: 10.3892/or.2012.1721. Epub 2012 Mar 13.


Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.

Yi BR, Hwang KA, Aboody KS, Jeung EB, Kim SU, Choi KC.

Stem Cell Res. 2014 Jan;12(1):36-48. doi: 10.1016/j.scr.2013.09.010. Epub 2013 Oct 1.


Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.

Joo KM, Park IH, Shin JY, Jin J, Kang BG, Kim MH, Lee SJ, Jo MY, Kim SU, Nam DH.

Mol Ther. 2009 Mar;17(3):570-5. doi: 10.1038/mt.2008.290. Epub 2009 Jan 6.


Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.

Kim DJ, Yi BR, Lee HR, Kim SU, Choi KC.

Oncol Rep. 2013 Sep;30(3):1129-36. doi: 10.3892/or.2013.2564. Epub 2013 Jun 25.


Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.

You MH, Kim WJ, Shim W, Lee SR, Lee G, Choi S, Kim DY, Kim YM, Kim H, Han SU.

J Gastroenterol Hepatol. 2009 Aug;24(8):1393-400. doi: 10.1111/j.1440-1746.2009.05862.x. Epub 2009 May 28.


Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.

Kang NH, Hwang KA, Yi BR, Lee HJ, Jeung EB, Kim SU, Choi KC.

Cancer Gene Ther. 2012 Jun;19(6):412-9. doi: 10.1038/cgt.2012.15. Epub 2012 Apr 13.


Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.

Wang C, Natsume A, Lee HJ, Motomura K, Nishimira Y, Ohno M, Ito M, Kinjo S, Momota H, Iwami K, Ohka F, Wakabayashi T, Kim SU.

Cancer Gene Ther. 2012 Nov;19(11):796-801. doi: 10.1038/cgt.2012.63. Epub 2012 Sep 28.


Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.

Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R, Deisseroth AB.

Blood. 1998 Jul 15;92(2):672-82.


Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.

Yi BR, Kim SU, Choi KC.

Int J Oncol. 2015 Jul;47(1):171-8. doi: 10.3892/ijo.2015.2999. Epub 2015 May 11.


Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.

Yi BR, Hwang KA, Kang NH, Kim SU, Jeung EB, Kim HC, Choi KC.

Cancer Gene Ther. 2012 Sep;19(9):644-51. doi: 10.1038/cgt.2012.45. Epub 2012 Jul 13.


Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.

Yi BR, Park MA, Lee HR, Kang NH, Choi KJ, Kim SU, Choi KC.

Mol Oncol. 2013 Jun;7(3):543-54. doi: 10.1016/j.molonc.2013.01.004. Epub 2013 Jan 19.


Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.

Kim JH, Kim JY, Kim SU, Cho KG.

Biochem Biophys Res Commun. 2012 Jan 6;417(1):534-40. doi: 10.1016/j.bbrc.2011.11.155. Epub 2011 Dec 8.


Cytosine deaminase-expressing human neural stem cells inhibit tumor growth in prostate cancer-bearing mice.

Lee HJ, Doo SW, Kim DH, Cha YJ, Kim JH, Song YS, Kim SU.

Cancer Lett. 2013 Jul 10;335(1):58-65. doi: 10.1016/j.canlet.2013.01.048. Epub 2013 Feb 4.


Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.

Torimura T, Ueno T, Taniguchi E, Masuda H, Iwamoto H, Nakamura T, Inoue K, Hashimoto O, Abe M, Koga H, Barresi V, Nakashima E, Yano H, Sata M.

Cancer Sci. 2012 Mar;103(3):542-8. doi: 10.1111/j.1349-7006.2011.02182.x. Epub 2012 Jan 25.


Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.

Pederson LC, Buchsbaum DJ, Vickers SM, Kancharla SR, Mayo MS, Curiel DT, Stackhouse MA.

Cancer Res. 1997 Oct 1;57(19):4325-32.

Supplemental Content

Support Center